BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 18176023)

  • 1. Enhancement of antigen-specific immunoglobulin G production in mice by co-administration of L-cystine and L-theanine.
    Kurihara S; Shibahara S; Arisaka H; Akiyama Y
    J Vet Med Sci; 2007 Dec; 69(12):1263-70. PubMed ID: 18176023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined administration of (L)-cystine and (L)-theanine enhances immune functions and protects against influenza virus infection in aged mice.
    Takagi Y; Kurihara S; Higashi N; Morikawa S; Kase T; Maeda A; Arisaka H; Shibahara S; Akiyama Y
    J Vet Med Sci; 2010 Feb; 72(2):157-65. PubMed ID: 19940390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity.
    Miyagawa K; Hayashi Y; Kurihara S; Maeda A
    Geriatr Gerontol Int; 2008 Dec; 8(4):243-50. PubMed ID: 19149835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystine and Theanine as Stress-Reducing Amino Acids-Perioperative Use for Early Recovery after Surgical Stress.
    Tsuchiya T; Kurihara S
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of postoperative recovery by preoperative oral co-administration of the amino acids, cystine and theanine, in a mouse surgical model.
    Shibakusa T; Mikami T; Kurihara S; Chiba Y; Tsuchiya T; Miyachi T; Oyama A; Tanaka KA; Koyama N
    Clin Nutr; 2012 Aug; 31(4):555-61. PubMed ID: 22348870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of Cystine and Theanine ameliorates oxaliplatin-induced chronic peripheral neuropathy in rodents.
    Kawashiri T; Kobayashi D; Egashira N; Tsuchiya T; Shimazoe T
    Sci Rep; 2020 Jul; 10(1):12665. PubMed ID: 32728157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of co-administration of adjuvants with a nanoparticle-based genetic vaccine delivery system on the resulting immune responses.
    Cui Z; Mumper RJ
    Eur J Pharm Biopharm; 2003 Jan; 55(1):11-8. PubMed ID: 12551699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses.
    Oka H; Emori Y; Kobayashi N; Hayashi Y; Nomoto K
    Int Immunopharmacol; 2001 Mar; 1(3):521-32. PubMed ID: 11367535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of the amino acids cystine and theanine attenuates the adverse events of S-1 adjuvant chemotherapy in gastrointestinal cancer patients.
    Tsuchiya T; Honda H; Oikawa M; Kakita T; Oyama A; Oishi H; Tochikubo K; Hashimoto T; Kurihara S; Shibakusa T; Kayahara T
    Int J Clin Oncol; 2016 Dec; 21(6):1085-1090. PubMed ID: 27306219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
    Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
    Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystine and Theanine Improve Survival after Gut Ischemia-Reperfusion.
    Miyakuni T; Fukatsu K; Ri M; Murakoshi S; Inoue Y; Kurihara S; Takayama T; Yasuhara H
    Ann Nutr Metab; 2018; 73(2):131-137. PubMed ID: 30056446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative oral administration of cystine and theanine enhances recovery after distal gastrectomy: a prospective randomized trial.
    Miyachi T; Tsuchiya T; Oyama A; Tsuchiya T; Abe N; Sato A; Chiba Y; Kurihara S; Shibakusa T; Mikami T
    JPEN J Parenter Enteral Nutr; 2013; 37(3):384-91. PubMed ID: 22972879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell-dependent immunoglobulin G2a anti-bovine serum albumin (BSA) response elicited by high molecular weight dextran-BSA conjugates associated with dextran-mediated macrophage-natural killer cell interaction.
    Ediriwickrema CP; Tonkonogy SL; Hammerberg B
    Immunology; 2000 Dec; 101(4):474-83. PubMed ID: 11122451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen dose-dependent differences in IgE antibody production are not due to polarization towards Th1 and Th2 cell subsets.
    Arps V; Sudowe S; Kölsch E
    Eur J Immunol; 1998 Feb; 28(2):681-6. PubMed ID: 9521078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo priming of CD4 T cells that produce interleukin (IL)-2 but not IL-4 or interferon (IFN)-gamma, and can subsequently differentiate into IL-4- or IFN-gamma-secreting cells.
    Wang X; Mosmann T
    J Exp Med; 2001 Oct; 194(8):1069-80. PubMed ID: 11602637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses.
    Nygaard UC; Aase A; Løvik M
    BMC Immunol; 2005 Jun; 6():11. PubMed ID: 15967044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens.
    Tani K; Murphy WJ; Chertov O; Salcedo R; Koh CY; Utsunomiya I; Funakoshi S; Asai O; Herrmann SH; Wang JM; Kwak LW; Oppenheim JJ
    Int Immunol; 2000 May; 12(5):691-700. PubMed ID: 10784615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of IL-12 during ongoing immune responses fails to permanently suppress and can even enhance the synthesis of antigen-specific IgE.
    Germann T; Guckes S; Bongartz M; Dlugonska H; Schmitt E; Kolbe L; Kölsch E; Podlaski FJ; Gately MK; Rüde E
    Int Immunol; 1995 Oct; 7(10):1649-57. PubMed ID: 8562510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production.
    Kim TS; DeKruyff RH; Rupper R; Maecker HT; Levy S; Umetsu DT
    J Immunol; 1997 May; 158(9):4137-44. PubMed ID: 9126973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
    Bliss J; Van Cleave V; Murray K; Wiencis A; Ketchum M; Maylor R; Haire T; Resmini C; Abbas AK; Wolf SF
    J Immunol; 1996 Feb; 156(3):887-94. PubMed ID: 8558014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.